Johnson & Johnson’s Xencor XNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.02M Hold
748,062
1.38% 8
2025
Q4
$11.5M Hold
748,062
2.06% 8
2025
Q3
$8.77M Hold
748,062
1.74% 9
2025
Q2
$6.09M Hold
748,062
1.82% 9
2025
Q1
$7.96M Hold
748,062
2.33% 9
2024
Q4
$17.2M Hold
748,062
4.45% 9
2024
Q3
$15M Hold
748,062
3.52% 10
2024
Q2
$14.2M Hold
748,062
3.53% 10
2024
Q1
$16.6M Hold
748,062
0.38% 12
2023
Q4
$15.9M Hold
748,062
0.36% 10
2023
Q3
$15.1M Hold
748,062
5.55% 5
2023
Q2
$18.7M Hold
748,062
5.8% 5
2023
Q1
$20.9M Hold
748,062
6.79% 5
2022
Q4
$19.5M Hold
748,062
5.67% 6
2022
Q3
$19.4M Hold
748,062
5.72% 7
2022
Q2
$20.5M Hold
748,062
5.23% 7
2022
Q1
$20M Hold
748,062
3.77% 10
2021
Q4
$30M Buy
+748,062
New +$28.4M 3.42% 8

Other funds holding XNCR

Johnson & Johnson's XNCR Position: Q1 2026 in Review

Johnson & Johnson held its Xencor (XNCR) position steady in Q1 2026 at 748,062 shares worth $9.02M. The position accounts for 1.38% of the portfolio, ranked #8.

Johnson & Johnson first reported a position in XNCR in Q4 2021 and has held it in 18 quarters since. The position peaked at $30M in Q4 2021. 203 funds tracked by Wall St. Rank hold XNCR as of Q1 2026.

  • Johnson & Johnson held 748,062 shares of Xencor worth $9.02M as of Q1 2026.
  • Johnson & Johnson left its Xencor share count unchanged in Q1 2026.
  • Xencor made up 1.38% of Johnson & Johnson's portfolio in Q1 2026, its #8 holding.
  • Johnson & Johnson first reported a position in Xencor in Q4 2021 and has held it in 18 quarters since.
  • Johnson & Johnson's Xencor position peaked at $30M in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Xencor as of Q1 2026.

Based on Johnson & Johnson's 13F filing for Q1 2026, filed 13 May 2026.